Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ince, P. G.
Right arrow Articles by Bates, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ince, P. G.
Right arrow Articles by Bates, D.
NEUROLOGY 1987;37:1231
© 1987 American Academy of Neurology

Demyelinating neuropathy due to primary IgM kappa B cell lymphoma of peripheral nerve

Paul G. Ince, MRCPath, Pamela J. Shaw, MRCP, Peter R. W. Fawcett, MRCP and David Bates, FRCP

Departments of Neurology and Histopathology, University of Newcastle upon Tyne, UK.

A 53-year-old man presented with a painful, demyelinating sensorimotor peripheral neuropathy with lymphomatous infiltration on sural nerve biopsy, but no evidence of systemic lymphoma. The neuropathy responded to cytotoxic therapy. Seven years later he developed generalized lymphadenopathy due to B cell lymphoplasmacytoid lymphoma, with a subpopulation of cells expressing a monoclonal pattern of IgM k. The lymphomatous infiltrate in the original nerve biopsy showed similar monoclonal IgM k reactivity. The mechanism of demyelination of the peripheral nerves may be similar to that described in patients with IgM k monoclonal gammopathies.

Address correspondence and reprint requests to Dr. Ince, Department of Histopathology, Royal Victoria Infirmary, Newcastle-upon-Tyne NE1 4LP, UK.

Received May 28, 1986. Accepted for publication in final form October 14, 1986.




This article has been cited by other articles:


Home page
Neuro Oncol DukeHome page
J. M. Baehring, D. Damek, E. C. Martin, R. A. Betensky, and F. H. Hochberg
Neurolymphomatosis
Neuro-oncol, April 1, 2003; 5(2): 104 - 115.
[Abstract] [PDF]


Home page
StrokeHome page
J. A. Clemens, D. T. Stephenson, E. B. Smalstig, E. P. Dixon, and S. P. Little
Global Ischemia Activates Nuclear Factor-{kappa}B in Forebrain Neurons of Rats
Stroke, May 1, 1997; 28(5): 1073 - 1081.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
D. A. Krendel, R. L. Stahl, and W. C. Chan
Lymphomatous Polyneuropathy: Biopsy of Clinically Involved Nerve and Successful Treatment
Arch Neurol, March 1, 1991; 48(3): 330 - 332.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. M. Shefner and D. M. Dawson
The Use of Sensory Action Potentials in the Diagnosis of Peripheral Nerve Disease
Arch Neurol, March 1, 1990; 47(3): 341 - 348.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.